All Patients Transferred Home on Warfarin or Direct Oral Anticoagulants Receive Written Information Prior to Transfer

Identifying Attributes

Care Settings
Care Transitions
Country
Australia
Publishing Organisation
Government of Western Australia, Department of Health: Clinical Audit Tool and Key Performance Indicators for High Risk Medication Policy
Type of Quality Indicator
Process
IOM Quality Dimension
Person-Centredness
Domain
Communication

Defining Attributes

Definition

Percentage of patients transferred home on warfarin or Direct Oral Anticoagulants that receive written information prior to transfer.

Numerator

Number of patients transferred home on warfarin or Direct Oral Anticoagulants that receive written information prior to transfer (inferred).

Denominator

Number of patients transferred home on warfarin or Direct Oral Anticoagulants (inferred).

Exclusions
Use of Risk Adjustment
No
Risk Adjustments
Stratifications

Data Attributes

Type of Data Collection
Surveys
Data Collection Methods

Recommended clinical indicators for health services to use to monitor the management of high risk medications. The decision to adopt a clinical indicator is to be determined by the health service's Medication Safety Governance Group (or Drug and Therapeutics Committee) determined by the high risk medication risk register and action plans of the health service

Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods

Not routinely collected and reported.

Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Technical Specifications
Link to Measurement Tools

Recommended clinical indicators for health services to use to monitor the management of high risk medications. The decision to adopt a clinical indicator is to be determined by the health service’s Medication Safety Governance Group (or Drug and Therapeutics Committee) determined by the high risk medication risk register and action plans of the health service

Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
No
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
23 July 2025